{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:48:36Z","timestamp":1746521316622},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T00:00:00Z","timestamp":1303257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00380-011-0141-5","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T09:31:46Z","timestamp":1303205506000},"page":"202-207","source":"Crossref","is-referenced-by-count":10,"title":["Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3\u03b2 pathway"],"prefix":"10.1007","volume":"27","author":[{"given":"Damien","family":"Gruson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Ginion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"Decroly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Lause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Vanoverschelde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Ketelslegers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Thissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,20]]},"reference":[{"key":"141_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-6147(02)01946-6","volume":"23","author":"FM Dautzenberg","year":"2002","unstructured":"Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23:71\u201377","journal-title":"Trends Pharmacol Sci"},{"key":"141_CR2","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1161\/CIRCULATIONAHA.105.584441","volume":"112","author":"JC Burnett Jr","year":"2005","unstructured":"Burnett JC Jr (2005) Urocortin: advancing the neurohumoral hypothesis of heart failure. Circulation 112:3544\u20133546","journal-title":"Circulation"},{"key":"141_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1568016043477341","volume":"2","author":"CJ Charles","year":"2004","unstructured":"Charles CJ, Rademaker MT, Richards AM (2004) Urocortins: putative role in cardiovascular disease. Curr Med Chem Cardiovasc Hematol Agents 2:43\u201347","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"141_CR4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.87.1.340","volume":"87","author":"Y Kimura","year":"2002","unstructured":"Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H (2002) Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87:340\u2013346","journal-title":"J Clin Endocrinol Metab"},{"key":"141_CR5","doi-asserted-by":"crossref","first-page":"H3031","DOI":"10.1152\/ajpheart.2000.279.6.H3031","volume":"279","author":"T Nishikimi","year":"2000","unstructured":"Nishikimi T, Miyata A, Horio T, Yoshihara F, Nagaya N, Takishita S, Yutani C, Matsuo H, Matsuoka H, Kangawa K (2000) Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol 279:H3031\u2013H3039","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"141_CR6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCHEARTFAILURE.108.840207","volume":"2","author":"SP Wright","year":"2009","unstructured":"Wright SP, Doughty RN, Frampton CM, Gamble GD, Yandle TG, Richards AM (2009) Plasma urocortin 1 in human heart failure. Circ Heart Fail 2:465\u2013471","journal-title":"Circ Heart Fail"},{"key":"141_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/CS20030311","volume":"106","author":"LL Ng","year":"2004","unstructured":"Ng LL, Loke IW, O\u2019Brien RJ, Squire IB, Davies JE (2004) Plasma urocortin in human systolic heart failure. Clin Sci 106:383\u2013388","journal-title":"Clin Sci"},{"key":"141_CR8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.peptides.2009.11.023","volume":"31","author":"D Gruson","year":"2010","unstructured":"Gruson D, Ahn SA, Ketelslegers JM, Rousseau MF (2010) Circulating levels of stress associated peptide urocortin in heart failure patients. Peptides 31:354\u2013356","journal-title":"Peptides"},{"key":"141_CR9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.bjp.0705985","volume":"143","author":"KE Wiley","year":"2004","unstructured":"Wiley KE, Davenport AP (2004) CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol 143:508\u2013514","journal-title":"Br J Pharmacol"},{"key":"141_CR10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/emboj\/19.11.2537","volume":"19","author":"T Shioi","year":"2000","unstructured":"Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19:2537\u20132548","journal-title":"EMBO J"},{"key":"141_CR11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","volume":"115","author":"GW Dorn","year":"2005","unstructured":"Dorn GW, Force T (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115:527\u2013537","journal-title":"J Clin Invest"},{"key":"141_CR12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbrc.2005.01.001","volume":"328","author":"A Chanalaris","year":"2005","unstructured":"Chanalaris A, Lawrence KM, Townsend PA, Davidson S, Jamshidi Y, Stephanou A, Knight RD, Hsu SY, Hsueh AJ, Latchman DS (2005) Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway. Biochem Biophys Res Commun 328:442\u2013448","journal-title":"Biochem Biophys Res Commun"},{"key":"141_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tcm.2007.01.004","volume":"17","author":"R Kerkela","year":"2007","unstructured":"Kerkela R, Woulfe K, Force T (2007) Glycogen synthase kinase-3beta\u2014actively inhibiting hypertrophy. Trends Cardiovasc Med 17:91\u201396","journal-title":"Trends Cardiovasc Med"},{"key":"141_CR14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","volume":"90","author":"SE Hardt","year":"2002","unstructured":"Hardt SE, Sadoshima J (2002) Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 90:1055\u20131063","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"141_CR15","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1038\/sj.bjp.0707659","volume":"153","author":"PH Sugden","year":"2008","unstructured":"Sugden PH, Fuller SJ, Weiss SC, Clerk A (2008) Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 153(Suppl 1):S137\u2013S153","journal-title":"Br J Pharmacol"},{"key":"141_CR16","doi-asserted-by":"crossref","unstructured":"Kim Y, Park MK, Chung S (2010) Protective effect of urocortin on 1-methyl-4-phenylpyridinium-induced dopaminergic neuronal death. Mol Cells 30(5):427\u2013433","DOI":"10.1007\/s10059-010-0132-x"},{"key":"141_CR17","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.4049\/jimmunol.179.9.6204","volume":"179","author":"MJ Wang","year":"2007","unstructured":"Wang MJ, Lin SZ, Kuo JS, Huang HY, Tzeng SF, Liao CH, Chen DC, Chen WF (2007) Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol 179:6204\u20136214","journal-title":"J Immunol"},{"key":"141_CR18","unstructured":"Huang HY, Lin SZ, Chen WF, Li KW, Kuo JS, Wang MJ (2009) Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3beta and histone deacetylase. Neurobiol Aging [Epub ahead of print]"},{"key":"141_CR19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.peptides.2010.04.009","volume":"31","author":"D Gruson","year":"2010","unstructured":"Gruson D, Ginion A, Decroly N, Lause P, Vanoverschelde JL, Ketelslegers JM, Bertrand L, Thissen JP (2010) Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt\/GSK-3beta signaling pathway. Peptides 31:1326\u20131333","journal-title":"Peptides"},{"key":"141_CR20","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.peptides.2005.05.021","volume":"26","author":"K Ikeda","year":"2005","unstructured":"Ikeda K, Tojo K, Otsubo C, Udagawa T, Hosoya T, Tajima N, Nakao K, Kawamura M (2005) Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes. Peptides 26:2473\u20132481","journal-title":"Peptides"},{"key":"141_CR21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/jmcc.2002.1529","volume":"34","author":"BK Brar","year":"2002","unstructured":"Brar BK, Stephanou A, Knight R, Latchman DS (2002) Activation of protein kinase B\/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia\/reoxygenation-induced cell death. J Mol Cell Cardiol 34:483\u2013492","journal-title":"J Mol Cell Cardiol"},{"key":"141_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/bbrc.1998.9297","volume":"250","author":"K Ikeda","year":"1998","unstructured":"Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T, Harada M, Nakagawa O, Nakao K (1998) Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem Biophys Res Commun 250:298\u2013304","journal-title":"Biochem Biophys Res Commun"},{"key":"141_CR23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","volume":"99","author":"CL Antos","year":"2002","unstructured":"Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM, Richardson JA, Hill JA, Olson EN (2002) Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 99:907\u2013912","journal-title":"Proc Natl Acad Sci USA"},{"key":"141_CR24","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI36245","volume":"118","author":"R Kerkela","year":"2008","unstructured":"Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, Beahm C, Greytak S, Woulfe K, Trivedi CM, Woodgett JR, Epstein JA, Force T, Huggins GS (2008) Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 118:3609\u20133618","journal-title":"J Clin Invest"},{"key":"141_CR25","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1074\/jbc.R800077200","volume":"284","author":"T Force","year":"2009","unstructured":"Force T, Woodgett JR (2009) Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J Biol Chem 284:9643\u20139647","journal-title":"J Biol Chem"},{"key":"141_CR26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00380-010-0006-3","volume":"25","author":"K Otsuka","year":"2010","unstructured":"Otsuka K, Terasaki F, Shimomura H, Tsukada B, Horii T, Isomura T, Suma H, Shibayama Y, Kitaura Y (2010) Enhanced expression of the ubiquitin\u2013proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress. Heart Vessels 25:474\u2013484","journal-title":"Heart Vessels"},{"key":"141_CR27","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1073\/pnas.0835895100","volume":"100","author":"S Haq","year":"2003","unstructured":"Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, Force T (2003) Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 100:4610\u20134615","journal-title":"Proc Natl Acad Sci USA"},{"key":"141_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/cyto.2001.1011","volume":"17","author":"JE Railson","year":"2002","unstructured":"Railson JE, Liao Z, Brar BK, Buddle JC, Pennica D, Stephanou A, Latchman DS (2002) Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes. Cytokine 17:243\u2013253","journal-title":"Cytokine"},{"key":"141_CR29","first-page":"25","volume":"49","author":"E Hiraoka","year":"2003","unstructured":"Hiraoka E, Kawashima S, Takahashi T, Rikitake Y, Hirase T, Yokoyama M (2003) PI 3-kinase-Akt-p70 S6 kinase in hypertrophic responses to leukemia inhibitory factor in cardiac myocytes. Kobe J Med Sci 49:25\u201337","journal-title":"Kobe J Med Sci"},{"key":"141_CR30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/0264-6021:3590119","volume":"359","author":"A O\u2019toole","year":"2001","unstructured":"O\u2019toole A, Moule SK, Lockyer PJ, Halestrap AP (2001) Tumour necrosis factor-alpha activation of protein kinase B in WEHI-164 cells is accompanied by increased phosphorylation of Ser473, but not Thr308. Biochem J 359:119\u2013127","journal-title":"Biochem J"},{"key":"141_CR31","doi-asserted-by":"crossref","first-page":"22892","DOI":"10.1074\/jbc.M011647200","volume":"276","author":"C Lu","year":"2001","unstructured":"Lu C, Schwartzbauer G, Sperling MA, Devaskar SU, Thamotharan S, Robbins PD, McTiernan CF, Liu JL, Jiang J, Frank SJ, Menon RK (2001) Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. J Biol Chem 276:22892\u201322900","journal-title":"J Biol Chem"},{"key":"141_CR32","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","volume":"281","author":"A Kenessey","year":"2006","unstructured":"Kenessey A, Ojamaa K (2006) Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6\u00a0K pathways. J Biol Chem 281:20666\u201320672","journal-title":"J Biol Chem"},{"key":"141_CR33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00380-009-1213-7","volume":"25","author":"JG He","year":"2010","unstructured":"He JG, Chen SL, Huang YY, Dong YG, Ma H (2010) The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1\/Smad2 expression. Heart Vessels 25:438\u2013443","journal-title":"Heart Vessels"},{"key":"141_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00380-009-1183-9","volume":"25","author":"K Omae","year":"2010","unstructured":"Omae K, Ogawa T, Yoshikawa M, Nitta K (2010) The use of H1-receptor antagonists and left ventricular remodeling in patients on chronic hemodialysis. Heart Vessels 25:163\u2013169","journal-title":"Heart Vessels"},{"key":"141_CR35","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2174\/138955709788922647","volume":"9","author":"F Hernandez","year":"2009","unstructured":"Hernandez F, Nido JD, Avila J, Villanueva N (2009) GSK3 inhibitors and disease. Mini Rev Med Chem 9:1024\u20131029","journal-title":"Mini Rev Med Chem"},{"key":"141_CR36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","volume":"3","author":"P Cohen","year":"2004","unstructured":"Cohen P, Goedert M (2004) GSK3 inhibitors development and therapeutic potential. Nat Rev Drug Discov 3:479\u2013487","journal-title":"Nat Rev Drug Discov"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-011-0141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-011-0141-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-011-0141-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:52:06Z","timestamp":1637531526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-011-0141-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,20]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["141"],"URL":"https:\/\/doi.org\/10.1007\/s00380-011-0141-5","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,20]]}}}